Genomma Lab Internacional, S.A.B. de C.V.

Genomma Lab Internacional, S.A.B. de C.V.verified

GNMLF

Price:

$1.27

Market Cap:

$1.30B

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico and internationally. It provides skin care, health and wellness, hair care, pain relief, cough and cold, gastro, sexual health, antiperspirant deodorant, hand sanitizer, isotonic deink, and razor products, as well as analgesics, antifungals, and hemorrhoids. The company offers its products under the Cicatricure, Asepxia, Teatrical, Goicoechea, Sistema GB, Medicasp, Tío Nacho, Vanart, Novamil, Ultra Bengue, X-Ray, Tafirol, Alliviax, Bufferin, Next, XL-3, Genoprazol, QG5, Kaopectate, Proctan, Nikzon, U...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2012-05-04

Stock Exchange

PNK

Ticker

GNMLF

The Enterprise Value as of November 2024 (TTM) for Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) is 4.74B

According to Genomma Lab Internacional, S.A.B. de C.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.74B. This represents a change of 135.51% compared to the average of 2.01B of the last 4 quarters.

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Historical Enterprise Value (quarterly & annually)

How has GNMLF Enterprise Value performed in the past?

The mean historical Enterprise Value of Genomma Lab Internacional, S.A.B. de C.V. over the last ten years is 1.63B. The current 4.74B Enterprise Value has changed 29.00% with respect to the historical average. Over the past ten years (40 quarters), GNMLF's Enterprise Value was at its highest in in the September 2024 quarter at 4.51B. The Enterprise Value was at its lowest in in the September 2023 quarter at 1.04B.

Quarterly (TTM)
Annual

Average

1.63B

Median

1.19B

Minimum

752.35M

Maximum

5.57B

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Genomma Lab Internacional, S.A.B. de C.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 413.72%

Maximum Annual Enterprise Value = 5.57B

Minimum Annual Increase = -33.27%

Minimum Annual Enterprise Value = 752.35M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20235.57B413.72%
20221.08B-15.71%
20211.29B8.49%
20201.19B-6.07%
20191.26B67.82%
2018752.35M-33.27%
20171.13B-17.14%
20161.36B33.49%

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Average Enterprise Value

How has GNMLF Enterprise Value performed in the past?

The current Enterprise Value of Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

2.65B

5-year avg

2.08B

10-year avg

1.63B

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Enterprise Value vs. Peers

How is GNMLF’s Enterprise Value compared to its peers?

Genomma Lab Internacional, S.A.B. de C.V.’s Enterprise Value is less than RAMM Pharma Corp. (0), greater than Speakeasy Cannabis Club Ltd. (2.88M), greater than City View Green Holdings Inc. (6.65M), less than Craftport Cannabis Corp. (9.03B), less than Hypera S.A. (20.14B), greater than Indivior PLC (1.39B), greater than YourWay Cannabis Brands Inc. (17.82M), greater than Cumberland Pharmaceuticals Inc. (18.90M), greater than Orexo AB (publ) (876.57M), less than Sumitomo Pharma Co., Ltd. (545.27B), greater than Indivior PLC (1.39B), greater than C21 Investments Inc. (35.01M), greater than RavenQuest BioMed Inc. (13.57M), greater than Bhang Inc. (-323622.00), greater than Willow Biosciences Inc. (11.94M), greater than Alpha Teknova, Inc. (415.19M), greater than Guardion Health Sciences, Inc. (-10475955.00), greater than Lifecore Biomedical, Inc. (400.55M), greater than Organogenesis Holdings Inc. (550.26M), greater than Petros Pharmaceuticals, Inc. (6.06M),

Build a custom stock screener for Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genomma Lab Internacional, S.A.B. de C.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genomma Lab Internacional, S.A.B. de C.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Genomma Lab Internacional, S.A.B. de C.V.'s Enterprise Value?

What is the highest Enterprise Value for Genomma Lab Internacional, S.A.B. de C.V. (GNMLF)?

What is the 3-year average Enterprise Value for Genomma Lab Internacional, S.A.B. de C.V. (GNMLF)?

What is the 5-year average Enterprise Value for Genomma Lab Internacional, S.A.B. de C.V. (GNMLF)?

How does the current Enterprise Value for Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) compare to its historical average?